The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 3; peer review: 2 approved, 1 approved with reservations]

Background: Circulating vaccine derived poliovirus (cVDPV) outbreaks remain a threat to polio eradication. To reduce cases of polio from cVDPV of serotype 2, the serotype 2 component of the vaccine has been removed from the global vaccine supply, but outbreaks of cVDPV2 have continued. The objective...

Full description

Bibliographic Details
Published in:	Gates Open Research
Main Authors:	Megan Auzenbergs, Grace Macklin, Holly Fountain, Kathleen M O'Reilly, Hil Lyons
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2023-04-01
Subjects:	polio vaccination eradication cVDPVs OPV eng
Online Access:	https://gatesopenresearch.org/articles/5-94/v3

Similar Items

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 2; peer review: 2 approved, 1 approved with reservations]
by: Megan Auzenbergs, et al.
Published: (2022-05-01)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 1; peer review: 2 approved, 1 approved with reservations]
by: Megan Auzenbergs, et al.
Published: (2021-06-01)

Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV)
by: Nima D. Badizadegan, et al.
Published: (2024-09-01)

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation [version 1; peer review: 1 approved, 2 approved with reservations]
by: Steven GF Wassilak, et al.
Published: (2023-04-01)

Detection of vaccine-derived poliovirus type-3 in sewage of Kathmandu Valley, Nepal
by: Rachana Mehta, et al.
Published: (2024-11-01)

Epidemiological Surveillance of Acute Flaccid Paralysis for Eradication of Poliomyelitis (A Brief Review)
by: Simeonova I., et al.
Published: (2024-03-01)

Eradication of wild poliovirus in Nigeria: Lessons learnt
by: Osmond C. Ekwebelem, et al.
Published: (2021-11-01)

Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024
by: Kimberly M. Thompson, et al.
Published: (2024-05-01)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
by: Madhu Chhanda Mohanty, et al.
Published: (2017-10-01)

Securing the Future: Strategies for Global Polio Vaccine Security Amid Eradication Efforts
by: Vachagan Harutyunyan, et al.
Published: (2024-12-01)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
by: Radboud J. Duintjer Tebbens, et al.
Published: (2018-08-01)

Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama
by: Magda Rojas-Bonilla, et al.
Published: (2021-07-01)

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States
by: Dominika A. Kalkowska, et al.
Published: (2024-12-01)

Environmental Surveillance for Polioviruses in Haïti (2017–2019): The Dynamic Process for the Establishment and Monitoring of Sampling Sites
by: Mary M. Alleman, et al.
Published: (2021-03-01)

Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
by: Kimberly M. Thompson, et al.
Published: (2019-07-01)

Vaccine-Derived Polioviruses Not Detected by Global Surveillance Screening Assay
by: Deepa K. Sharma, et al.
Published: (2015-10-01)

Eradikasi Polio
by: Hindra Irawan Satari, et al.
Published: (2017-01-01)

Poliovirus vaccination during the endgame: insights from integrated modeling
by: Radboud J. Duintjer Tebbens, et al.
Published: (2017-06-01)

Polio eradication surveillance in Sri Lanka, 2019-2023
by: M.A.Y. Fernando, et al.
Published: (2024-06-01)

Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
by: Muhammad Atif Habib, et al.
Published: (2023-09-01)

Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine
by: Hasmik Manukyan, et al.
Published: (2022-08-01)

Monitoring the VDPV2 outbreak in Egypt during 2020–2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus
by: Menna R. Shabana, et al.
Published: (2024-08-01)

Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
by: T. Jacob John, et al.
Published: (2022-11-01)

Development of RT-PCR Assays for Simple Detection and Identification of Sabin Virus Contaminants in the Novel Oral Poliovirus Vaccines
by: Olga Singh, et al.
Published: (2025-01-01)

Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
by: Jiawei Xu, et al.
Published: (2024-05-01)

Evaluation of 17 years of MERIN (Meningitis and Encephalitis register in Lower Saxony, Germany) surveillance system: participants acceptability survey, completeness and timeliness of data
by: Anna Łuczyńska, et al.
Published: (2024-01-01)

Effect of national immunisation campaigns with oral polio vaccine on all-cause mortality in children in rural northern Ghana: 20 years of demographic surveillance cohort dataResearch in context
by: Paul Welaga, et al.
Published: (2023-12-01)

ACUTE FLACCID PARALYSIS REGISTERED FOR THE PERIOD 2012-2020, IN STARA ZAGORA REGION
by: I. Simeonova, et al.
Published: (2021-06-01)

Communicable Episode 18: The Nightmare Series, part 4 – rubella & polio
by: Kathryn Hostettler, et al.
Published: (2025-06-01)

Culture-Independent Detection of Poliovirus in Stool Samples by Direct RNA Extraction
by: Chelsea Harrington, et al.
Published: (2021-12-01)

Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine
by: Hasmik Manukyan, et al.
Published: (2024-06-01)

Surveillance of poliomyelitis in Northern Italy: Results of acute flaccid paralysis surveillance and environmental surveillance, 2012–2015
by: Laura Pellegrinelli, et al.
Published: (2017-02-01)

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine
by: Corey M. Peak, et al.
Published: (2024-11-01)

Reproductive and Mortality Outcomes in Wistar Rats Following Oral Polio Vaccine Administration
by: Ibrahim Baffa Musa Anda, et al.
Published: (2025-06-01)

Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I
by: Madhu Chhanda Mohanty, et al.
Published: (2023-07-01)

A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome
by: Jon Kim Andrus, et al.
Published: (2025-12-01)

Oral polio vaccine stockpile modeling: insights from recent experience
by: Kimberly M. Thompson, et al.
Published: (2023-12-01)

Polio eradication in Pakistan: Hope against hope or are we near eradication?
by: Tauseef Ahmad, et al.
Published: (2024-03-01)

Some lessons for malaria from the Global Polio Eradication Initiative
by: Matiana González-Silva, et al.
Published: (2021-05-01)

Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2
by: Hasmik Manukyan, et al.
Published: (2021-06-01)